CASP8 and breast cancer: After 24 h incubation of human breast cancer cells with the tested compound, the concentration of Casp-8 was 1.012 ng/mL (1 μM Les-3331) and 1.067 ng/mL (5 μM Les-3331), compared to the untreated control (0.828 ng/mL).